NCT03907605View on ClinicalTrials.gov

Anti-Mullerian Hormone (AMH) is a Marker for Ovarian Reserve. There Are Many Studies About AMH Changes in Ovarian Surgery, But Little is Known for Other Surgeries. We Seek to Investigate the Hormone Variations Before and After Uterine Artey Ligation for Postpartum Hemorrage (PPH)

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

March 1, 2019

Study Completion Date

April 1, 2019

Conditions

Anti-Mullerian Hormone DeficiencyPost Partum Hemorrhage

Interventions

OTHER

anti- mullerian hormone

All patients belong to the same group. The blood samples will be collected at the time of surgery and 3 months after surgery from the patients who need uterine artery ligation for PPH. The blood samples will be centrifuged within 2 hours after being obtained and assessed on the same day. AMH concentrations will be measured with an enzymatically amplified two-sided immunoassay

Trial Locations (1)

34000

Pinar Yalcin Bahat, Istanbul

All Listed Sponsors

lead

Kanuni Sultan Suleyman Training and Research Hospital

OTHER

NCT03907605 - Anti-Mullerian Hormone (AMH) is a Marker for Ovarian Reserve. There Are Many Studies About AMH Changes in Ovarian Surgery, But Little is Known for Other Surgeries. We Seek to Investigate the Hormone Variations Before and After Uterine Artey Ligation for Postpartum Hemorrage (PPH) | Biotech Hunter | Biotech Hunter